<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:GILD="http://gilead.com/20240322">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_GILD_gilead.com_20240322 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20240322_20240322 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0000882095 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:AmendmentFlag" id="ixv-314">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:EntityCentralIndexKey" id="ixv-315">0000882095</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gild-20240322.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-03-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-22</xbrli:startDate>
        <xbrli:endDate>2024-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.55pt; text-align: center"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 2.6pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20240322__20240322_z2pIZijf39L4"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:DocumentType" id="ixv-335">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 176.1pt 0pt 176.35pt; text-align: center; text-indent: -0.05pt"><b>Pursuant
to Section 13 or 15(d) of<br/>
 The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"><b>DATE OF REPORT (DATE OF EARLIEST
EVENT REPORTED):</b> <b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20240322__20240322_z0xw7lPwQNgj"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-336">March 22, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20240322__20240322_zttLEf7nFbF3"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:EntityRegistrantName" id="ixv-337">GILEAD SCIENCES, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.6pt; text-align: center">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20240322__20240322_zassUmUbrNYa"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-338">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityFileNumber_c20240322__20240322_z2SrtMZ4vAmc"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:EntityFileNumber" id="ixv-339">0-19731</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20240322__20240322_zifYn0bmKi8f"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:EntityTaxIdentificationNumber" id="ixv-340">94-3047598</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of<br/>
incorporation)</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File No.)</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer<br/>
Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20240322__20240322_zHYbuaBkGvPd"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:EntityAddressAddressLine1" id="ixv-341">333 Lakeside Drive</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressCityOrTown_c20240322__20240322_zOcYsLDd1uNa"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:EntityAddressCityOrTown" id="ixv-342">Foster City</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20240322__20240322_zU7WOli7GCz5"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-343">California</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20240322__20240322_zS9CZHJRZn29"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:EntityAddressPostalZipCode" id="ixv-344">94404</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center">(Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center">(<span id="xdx_901_edei--CityAreaCode_c20240322__20240322_zrVoKvs53tuh"><b><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:CityAreaCode" id="ixv-345">650</ix:nonNumeric></b></span>) <b><span id="xdx_905_edei--LocalPhoneNumber_c20240322__20240322_zK4HGARhf7Fe"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:LocalPhoneNumber" id="ixv-346">574-3000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.75pt 0pt 5.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90D_edei--WrittenCommunications_c20240322__20240322_zf92VBf5x5N8"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="ixv-347">&#168;</ix:nonNumeric></span></span></span> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20240322__20240322_zSrPnJosC7Oe"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="ixv-348">&#168;</ix:nonNumeric></span></span></span> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementTenderOffer_c20240322__20240322_z0D6jDWY0Wo3"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="ixv-349">&#168;</ix:nonNumeric></span></span></span> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20240322__20240322_zeouy0LxpJWj"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="ixv-350">&#168;</ix:nonNumeric></span></span></span> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Securities registered pursuant to Section 12(b) of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border: black 1pt solid; width: 35%; font-size: 10pt; text-align: center">Title of each class</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 31%; font-size: 10pt; text-align: center">Trading Symbol(s)</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Name of each exchange on which<br/>
 registered</p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font-size: 10pt; text-align: center"><b><span id="xdx_90E_edei--Security12bTitle_c20240322__20240322_zdA5GyU8iJfi"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:Security12bTitle" id="ixv-351">Common Stock, par value, $0.001 per share</ix:nonNumeric></span></b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><b><span id="xdx_902_edei--TradingSymbol_c20240322__20240322_zrcEc0R46zk4"><ix:nonNumeric contextRef="AsOf2024-03-22" name="dei:TradingSymbol" id="ixv-352">GILD</ix:nonNumeric></span></b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><b><span id="xdx_900_edei--SecurityExchangeName_c20240322__20240322_zX78h3cIj8Yb"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-353">The Nasdaq Global Select Market</ix:nonNumeric></span></b></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Emerging
growth company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20240322__20240322_zgf01yIqCvdd"><ix:nonNumeric contextRef="AsOf2024-03-22" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-354">&#168;</ix:nonNumeric></span></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-top: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"/><td style="width: 10%; text-align: left"><b>Item 7.01.</b></td><td style="text-align: justify; width: 90%"><b>Regulation FD Disclosure.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On March&#160;22, 2024, Gilead Sciences, Inc.,
a Delaware corporation (&#8220;<span style="text-decoration: underline">Parent</span>&#8221; or &#8220;<span style="text-decoration: underline">Gilead</span>&#8221;),
issued a press release announcing the completion of the acquisition of the CymaBay Therapeutics, Inc., a Delaware corporation (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;),
a copy of which is attached as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K and incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The information in Item 7.01 and Item 9.01 of
this Form 8-K and Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the &#8220;<span style="text-decoration: underline">Exchange Act</span>&#8221;), or otherwise subject to the liabilities under that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general
incorporation language in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 10%"><b>Item 8.01.</b></td><td style="width: 90%"><b>Other Events.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">As previously disclosed, on February&#160;11,
2024, Gilead  entered into an Agreement and Plan of Merger (the &#8220;<span style="text-decoration: underline">Merger Agreement</span>&#8221;), among Parent, the Company and
Pacific Merger Sub,&#160;Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (&#8220;<span style="text-decoration: underline">Purchaser</span>&#8221;). In accordance
with the terms of the Merger Agreement, on March&#160;22, 2024, Gilead completed the acquisition of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the Merger Agreement, and upon the
terms and subject to the conditions thereof, on February&#160;23, 2024, Purchaser commenced a tender offer (the &#8220;<span style="text-decoration: underline">Offer</span>&#8221;),
to purchase all of the issued and outstanding shares (the &#8220;<span style="text-decoration: underline">Shares</span>&#8221;) of common stock, par value $0.0001 per share, of
the Company (other than (i)&#160;Shares owned immediately prior to the effective time of the Merger by the Company (including those held
in the treasury of the Company) and (ii)&#160;Shares owned both as of the commencement date of the Offer and immediately prior to the
effective time of the Merger by Parent, Purchaser or any other direct or indirect wholly owned subsidiary of Parent) at a price of $32.50
per Share (the &#8220;<span style="text-decoration: underline">Offer Price</span>&#8221;), net to the seller in cash, without interest, and subject to any required withholding
of taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Offer expired at one minute after 11:59
p.m., Eastern Time, on March&#160;21, 2024. According to Equiniti Trust Company, LLC, the depositary for the Offer, 93,682,371
Shares were validly tendered and not withdrawn in the Offer, representing approximately 77.3% of the outstanding Shares (not
including 5,095,996 Shares delivered through Notices of Guaranteed Delivery, representing approximately 4.2% of the Shares
outstanding). The number of Shares tendered satisfied the condition to the Offer that there be validly tendered and not validly
withdrawn Shares that, considered together with all other Shares (if any) owned by Purchaser and its affiliates (as such term is
defined in Section&#160;251(h)(6)&#160;of the General Corporation Law of the State of Delaware (the &#8220;<span style="text-decoration: underline">DGCL</span>&#8221;)),
represent one more Share than 50% of the total number of Shares outstanding at the expiration of the Offer (including, for the
avoidance of doubt, all Shares that become outstanding as a result of the &#8220;cashless exercise&#8221; of the warrants to
purchase Shares); <i>provided</i>, <i>however</i>, that Shares tendered in the Offer that have not been &#8220;received&#8221; by
the &#8220;depository&#8221; (as such terms are defined in Section&#160;251(h)(6)&#160;of the DGCL shall be excluded). All
conditions to the Offer having been satisfied or waived, Gilead and Purchaser accepted for payment all Shares validly tendered and
not validly withdrawn.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Following the consummation of the Offer, the remaining
conditions to the Merger set forth in the Merger Agreement were satisfied or waived, and on March&#160;22, 2024, Purchaser merged with
and into the Company pursuant to Section&#160;251(h)&#160;of the DGCL, with the Company being the surviving corporation (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;).
Each Share outstanding immediately prior to the effective time of the Merger (other than (i)&#160;Shares owned immediately prior to the
effective time of the Merger by the Company (including those held in the treasury of the Company), (ii)&#160;Shares owned both as of the
commencement date of the Offer and immediately prior to the effective time of the Merger by Parent, Purchaser, or any other direct or
indirect wholly owned subsidiary of Parent, (iii)&#160;Shares irrevocably accepted by Purchaser for purchase pursuant to the Offer and
(iv)&#160;Shares held by stockholders who have properly exercised and perfected their demands for appraisal of such Shares in accordance
with the DGCL and have neither withdrawn nor lost such rights prior to the effective time of the Merger) was converted into the right
to receive an amount in cash equal to the Offer Price, net to the seller in cash, without interest, and subject to any required withholding
of taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The aggregate consideration paid by Gilead to
acquire the Shares in the Offer and Merger was approximately $4.3 billion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 10%"><b>Item 9.01.</b></td><td style="width: 90%"><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following Exhibit 99.1 is furnished pursuant to this Item 9.01.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; width: 8%"><b>Exhibit&#160;<br/>
Number</b></td>
    <td style="width: 2%">&#160;</td>
<td style="border-bottom: Black 1pt solid; width: 90%"><b>Description</b></td></tr>
<tr style="vertical-align: top">
<td style="font-size: 10pt"><a href="tm249475d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
<td style="font-size: 10pt"><a href="tm249475d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated March&#160;22, 2024.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font-size: 10pt">&#160;</td>
    <td>&#160;</td>
<td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
<td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td>&#160;</td>
<td colspan="3" style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GILEAD SCIENCES,&#160;INC.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
<td colspan="3" style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
<td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
<td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Andrew Dickinson</span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
<td style="font-size: 10pt; width: 3%">&#160;</td>
<td style="font-size: 10pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
<td style="font-size: 10pt; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Dickinson</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
<td style="font-size: 10pt">&#160;</td>
<td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
<td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#160;22, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



</body>
</html>
